Oxalic Acid

Oxalic Acid

SCHEMBL7590221

C[C@@H]1C[C@H](O)C[C@H](c2ccsc2)N1.O=C(O)C(=O)O

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.34
PKM P14618 1/20 0.34
ADORA2B P29275 14/20 0.33
ALDH1A1 P00352 2/20 0.33
POLB P06746 1/20 0.33
HSD17B10 Q99714 2/20 0.33
TSHR P16473 1/20 0.33
KDM4E B2RXH2 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
LMNA P02545 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MCL1 Q07820 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL7590217 1.00 HCAR2 (0.34) HCAR2PKMADORA2BALDH1A1POLB
SCHEMBL7688215 0.93 PKM (0.33) HCAR2PKMADORA2BALDH1A1POLB
SCHEMBL7688213 0.93 PKM (0.33) HCAR2PKMADORA2BALDH1A1POLB
Hydrochloric Acid SCHEMBL7594207 0.91 PKM (0.32) PKMADORA2BALDH1A1POLBHSD17B10
Hydrochloric Acid SCHEMBL7594212 0.91 PKM (0.32) PKMADORA2BALDH1A1POLBHSD17B10
Oxalic Acid SCHEMBL7595700 0.81 MEN1 (0.41) ALDH1A1LMNASMN1; SMN2
Oxalic Acid SCHEMBL7595702 0.81 MEN1 (0.41) ALDH1A1LMNASMN1; SMN2
Oxalic Acid SCHEMBL7592810 0.78 HCAR2 (0.37) HCAR2PKMADORA2BALDH1A1POLB
Oxalic Acid SCHEMBL7592807 0.78 HCAR2 (0.37) HCAR2PKMADORA2BALDH1A1POLB
SCHEMBL6980945 0.74 MEN1 (0.46) GAALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6451789-B1 CENTRAL NERVOUS SYSTEM DISORDERS; COGNITION ACTIVATORS LES LABORTOIRES SERVIER (FR) 2002-09-17 US disclosed
US-20020042413-A1 1-aza-2-alkyl-6-aryl-cycloalkanes RAULT SYLVAIN (FR) 2002-04-11 US disclosed
US-6323222-B1 COGNITION ACTIVATORS, ALZHEIMER*S DISEASE AND ENZYME INHIBITORS ADIR ET COMPAGNIE (FR) 2001-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020042413-A1 1-aza-2-alkyl-6-aryl-cycloalkanes SULT2A1, GRIN2A, NR3C1 HCAR2 50/4885PKM 2891/4885ADORA2B 52/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.